Nov 5, 2022
Tobias Reichmuth — the longevity market starts now
Posted by Kelvin Dafiaghor in categories: biotech/medical, life extension
Dr talks taking hardcore science to market without biotech approval risk and the catalyst that is translational research.
We were lucky enough to attend the Longevity Investors Conference last month; this key event attracts those interested in learning about longevity investment opportunities and finding out more about the exciting directions in which the field is accelerating. To put it succinctly, as MIT Tech Review did recently, LIC “brings academic scientists and biotech companies together with deep-pocketed investors. We’re talking millionaires and billionaires.”
Continue reading “Tobias Reichmuth — the longevity market starts now” »